Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
365,59 Mrd. | 2,49 % | 4/6 | 25,40 % | -29,97 % | 20,95 % | DOWN |
|
Amgen NasdaqGS:AMGN |
184,67 Mrd. | 7,37 % | 3/6 | 2,72 % | -5,43 % | 2,17 % | UP |
|
Gilead Sciences NasdaqGS:GILD |
173,93 Mrd. | 3,30 % | 5/6 | 4,53 % | -59,08 % | 14,18 % | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
43,81 Mrd. | 46,06 % | 4/6 | 49,91 % | 1,49 % | 36,22 % | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 Mrd. | 0,00 % | 4/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
Biogen NasdaqGS:BIIB |
25,29 Mrd. | -10,57 % | 1/6 | -1,25 % | 10,65 % | 18,08 % | UP |
|
Incyte NasdaqGS:INCY |
18,88 Mrd. | 41,79 % | 5/6 | 8,74 % | 27,87 % | 12,27 % | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,81 Mrd. | 12,22 % | 5/6 | 45,50 % | 62,96 % | 67,23 % | DOWN |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
8,56 Mrd. | 48,13 % | 5/6 | -45,97 % | 19,13 % | 30,89 % | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 Mrd. | 45,26 % | 4/6 | 42,18 % | -48,48 % | 0,64 % | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 Mrd. | -59,17 % | 2/6 | 0,00 % | -652349,57 % | -100,00 % | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 Mrd. | 0,00 % | 0,00 % | 0,00 % | 0,00 % | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,54 Mrd. | 19,97 % | 5/6 | 59,76 % | -47,66 % | 0,35 % | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,93 Mrd. | 0,00 % | 0/4 | 0,00 % | 0,00 % | 193,25 % | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,81 Mrd. | 29,02 % | 5/6 | 15,27 % | -27,87 % | 45,61 % | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 Mrd. | 0,00 % | 0/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 Mrd. | 0,00 % | 1/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,05 Mrd. | 40,93 % | 5/6 | 5,58 % | 23,21 % | 40,11 % | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,94 Mrd. | 10,07 % | 5/6 | 42,67 % | -59,79 % | 31,95 % | UP |
|
BioCryst Pharmaceuticals NasdaqGS:BCRX |
2,38 Mrd. | 110,83 % | 5/6 | -11,42 % | 27,39 % | 111,19 % | UP |
